Advances in clinical NK cell studies: Donor selection, manufacturing and quality control Jul 20, 2023 | Uncategorized
CD19-CAR engineered NK-92 cells are sufficient to overcome NK cell resistance in B-cell malignancies Jul 20, 2023 | Uncategorized
Continuously expanding CAR NK-92 cells display selective cytotoxicity against B-cell leukemia and lymphoma Jul 20, 2023 | Uncategorized
Direct and antibody-dependent cell-mediated cytotoxicity of head and neck squamous cell carcinoma cells by high-affinity natural killer cells Jul 20, 2023 | Uncategorized
The human IL-15 superagonist N-803 promotes migration of virus-specific CD8+ T and NK cells to B cell follicles but does not reverse latency in ART-suppressed, SHIV-infected macaques Jul 20, 2023 | HIV
